Delivery Order SPE2DR25D3010-SPE2DR26F88KB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,773.18 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,266.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Protonix 40 mg suspension. This non-competitive delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,464.45 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Protonix 40 mg suspension in 30-unit quantities. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-competitive, non-set-aside award. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count) under a firm fixed-price contract. The award, issued on October 28, 2025, carries a ceiling value of $1,156.78 and is scheduled for completion by October 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of PROTONIX 40 MG SUSPENSION 30S medical supplies to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,879.27 and is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.15 to AmerisourceBergen Drug Corp for the supply of Protonix DR 40 mg tablets (90-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Protonix is a proton pump inhibitor medication commonly used to treat...
- The Defense Logistics Agency awarded a $1,789.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pantoprazole Sodium delayed-release 40 mg tablets (90-count supply) on January 2, 2026, with completion scheduled for January 5, 2026. The award was made on a competitive basis without any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $89,140 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 4561815530 units of the proton pump inhibitor drug Protonix IV in 40mg vials. The single day order from August 15-16, 2023 will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania to support the Department of Defense's medical supply needs. As a top tier subcontractor to DLA's prime vendor programs, Amerisourcebergen regularly provides...
- The Defense Logistics Agency awarded a $230,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PROTONIX 40 MG SUSPENSION 30S. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania location to the Defense Logistics Agency by July 31, 2023 to support the agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency is the Department of Defense's combat logistics...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $1,754 to supply 4561731721 units of the drug Protonix IV in 40mg vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 7 through August 8, 2023. The Defense Logistics Agency functions to support the logistical needs of the U.S. Department of Defense and coordinates procurement and distribution...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88KBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,345.81 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of January 5, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The contract award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, and medical commodities to military healthcare programs worldwide. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the DLA's Medical Supply Chain, fulfilling routine pharmaceutical procurement needs across the Defense Health Agency and other government healthcare systems. The firm fixed-price structure and relatively modest order value reflect the transactional nature of delivery orders placed against the broader IDC framework, allowing the federal government to procure essential medications efficiently while maintaining competitive pricing discipline. The award demonstrates the company's capability to meet federal procurement requirements for both high-volume therapeutic domains and specialized pharmaceutical products supporting military operations and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/1/26 |